These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33257453)

  • 21. In vitro and in vivo evaluation of cnicin from blessed thistle (Centaurea benedicta) and its inclusion complexes with cyclodextrins against Schistosoma mansoni.
    Queiroz LS; Ferreira EA; Mengarda AC; Almeida ADC; Pinto PF; Coimbra ES; de Moraes J; Denadai ÂML; Da Silva Filho AA
    Parasitol Res; 2021 Apr; 120(4):1321-1333. PubMed ID: 33164156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni.
    El-Moslemany RM; Eissa MM; Ramadan AA; El-Khordagui LK; El-Azzouni MZ
    Acta Trop; 2016 Jul; 159():142-8. PubMed ID: 27039667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma.
    Koehne E; Zander N; Rodi M; Held J; Hoffmann W; Zoleko-Manego R; Ramharter M; Mombo-Ngoma G; Kremsner PG; Kreidenweiss A
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009511. PubMed ID: 34166393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of carvacryl acetate in vitro and following oral administration to mice harboring either prepatent or patent Schistosoma mansoni infections.
    Silva BC; Mengarda AC; Rodrigues VC; Cajas RA; Carnaúba PU; Espírito-Santo MCC; Bezerra-Filho CSM; de Sousa DP; de Moraes J
    Parasitol Res; 2021 Nov; 120(11):3837-3844. PubMed ID: 34604934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antischistosomal properties of aurone derivatives against juvenile and adult worms of Schistosoma mansoni.
    Pereira VRD; da Silveira LS; Mengarda AC; Alves Júnior IJ; da Silva OOZ; Miguel FB; Silva MP; Almeida ADC; Torres DDS; Pinto PF; Coimbra ES; de Moraes J; Couri MRC; da Silva Filho AA
    Acta Trop; 2021 Jan; 213():105741. PubMed ID: 33159900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo anti-schistosomal activity of the alkylphospholipid analog edelfosine.
    Yepes E; Varela-M RE; López-Abán J; Dakir el H; Mollinedo F; Muro A
    PLoS One; 2014; 9(10):e109431. PubMed ID: 25302497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Effect of Diminazene Aceturate on Parasitic Blood Fluke Schistosoma mansoni Infection.
    de Brito MG; Mengarda AC; Oliveira GL; Cirino ME; Silva TC; de Oliveira RN; Allegretti SM; de Moraes J
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naturally Occurring Cardenolides Affecting
    Keiser J; Koch V; Deckers A; Cheung HTA; Jung N; Bräse S
    ACS Infect Dis; 2020 Jul; 6(7):1922-1927. PubMed ID: 32364372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy.
    Bustinduy AL; Waterhouse D; de Sousa-Figueiredo JC; Roberts SA; Atuhaire A; Van Dam GJ; Corstjens PL; Scott JT; Stanton MC; Kabatereine NB; Ward S; Hope WW; Stothard JR
    mBio; 2016 Aug; 7(4):. PubMed ID: 27507822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals.
    Utzinger J; Chollet J; You J; Mei J; Tanner M; Xiao S
    Acta Trop; 2001 Sep; 80(1):9-18. PubMed ID: 11495639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Docking-Based Virtual Screening Enables Prioritizing Protein Kinase Inhibitors With
    Moreira BP; Batista ICA; Tavares NC; Armstrong T; Gava SG; Torres GP; Mourão MM; Falcone FH
    Front Cell Infect Microbiol; 2022; 12():913301. PubMed ID: 35865824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems.
    Guidi A; Lalli C; Perlas E; Bolasco G; Nibbio M; Monteagudo E; Bresciani A; Ruberti G
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004928. PubMed ID: 27518281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between infection intensity, serum immunoglobulin profile, cellular immunity and the efficacy of treatment with praziquantel in murine schistosomiasis mansoni.
    Nessim NG; Demerdash Z
    Arzneimittelforschung; 2000 Feb; 50(2):173-7. PubMed ID: 10719623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni.
    Eissa MM; El-Azzouni MZ; El-Khordagui LK; Abdel Bary A; El-Moslemany RM; Abdel Salam SA
    Acta Trop; 2020 Dec; 212():105714. PubMed ID: 32950482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epiisopilosine alkaloid has activity against Schistosoma mansoni in mice without acute toxicity.
    Guimarães MA; de Oliveira RN; de Almeida RL; Mafud AC; Sarkis ALV; Ganassin R; da Silva MP; Roquini DB; Veras LM; Sawada TCH; Ropke CD; Muehlmann LA; Joanitti GA; Kuckelhaus SAS; Allegretti SM; Mascarenhas YP; de Moraes J; Leite JRSA
    PLoS One; 2018; 13(5):e0196667. PubMed ID: 29750792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni.
    Panic G; Vargas M; Scandale I; Keiser J
    PLoS Negl Trop Dis; 2015; 9(7):e0003962. PubMed ID: 26230921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterisation of the tegument-expressed aldehyde dehydrogenase SmALDH_312 of Schistosoma mansoni, a target of disulfiram.
    Beutler M; Harnischfeger J; Weber MHW; Hahnel SR; Quack T; Blohm A; Ueberall ME; Timm T; Lochnit G; Rennar GA; Gallinger TL; Houhou H; Rahlfs S; Falcone FH; Becker K; Schlitzer M; Haeberlein S; Czermak P; Salzig D; Grevelding CG
    Eur J Med Chem; 2023 May; 251():115179. PubMed ID: 36948075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.
    de Oliveira RN; Rehder VL; Oliveira AS; Jeraldo Vde L; Linhares AX; Allegretti SM
    Exp Parasitol; 2014 Apr; 139():63-72. PubMed ID: 24602876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.